22 results
Thumbnail

D1.244 - Clinical heterogeneity of pediatric atopic dermatitis: latent class analysis

Thumbnail

D1.241 - Clinical and Immunological Phenotypes of Alopecia Areata in Children with Atopic Dermatitis

Thumbnail

D1.236 - The role of tissue resident memory cells in immunodermatological disorders: A Systematic Review

Thumbnail

D1.237 - Mental Health and Neurodevelopmental Comorbidities in Pediatric Atopic Dermatitis: A Retrospective Study and Literature-Based Perspective

Thumbnail

D1.245 - The role of advanced glycation end products as facilitating factors in the pathogenesis of atopic dermatitis in pediatric patients

Thumbnail

D1.246 - Characterization of Unmet Need for Targeted Precision Medication in Atopic Dermatitis Due to Inadequate Response or Adverse Reactions to Dupilumab

Thumbnail

D2.151 - HZ-Y030, an Oral STAT6 Degrader, Attenuates Type 2 Inflammation in Preclinical Asthma Models

Thumbnail

D2.152 - Clinical and functional characteristics of patients with suspected epoxy resin-related occupational asthma

Thumbnail

D2.155 - Mapping the Architecture and Spectrum of the Cough Hypersensitivity Questionnaire Across Respiratory Diseases

Thumbnail

D2.158 - Circulating 1-methylnicotinamide can predict the treatment response of dupilumab in adult asthma

Thumbnail

D2.157 - Clinical remission with tezepelumab in severe asthma: prevalence and predictors in a real-world multicentre study

Thumbnail

D2.159 - Idiopathic Chronic Eosinophilic Pneumonia: A Case Series

Thumbnail

D2.160 - Household Overcrowding and Number of Siblings as Risk Factors for Uncontrolled Asthma in Inner-City Children

Thumbnail

D2.161 - Exploring the Early-Life Interplay Between Respiratory Health and Neurodevelopmental disorders

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD

Thumbnail

D2.456 - Chronic sinusitis with nasal polyposis: Add-on aspirin desensitization useful in dupilumab therapy?